Clinical Trial Update: ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System [NA]

View source ↗

Summary

The ARISTOCRAT-A randomized trial evaluating closure after access with the AXERA 2 Access System in coronary artery disease patients was terminated. Results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AXERA 2 Access System

Snippet

Sponsor: Frank Saltiel | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2017-08-18